These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28921256)

  • 1. Relation Between Different Measures of Glycemic Exposure and Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes Mellitus: An Observational Cohort Study.
    van Wijngaarden RPT; Overbeek JA; Heintjes EM; Schubert A; Diels J; Straatman H; Steyerberg EW; Herings RMC
    Diabetes Ther; 2017 Oct; 8(5):1097-1109. PubMed ID: 28921256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study.
    Kim KJ; Choi J; Bae JH; Kim KJ; Yoo HJ; Seo JA; Kim NH; Choi KM; Baik SH; Kim SG; Kim NH
    Diabetes Metab J; 2021 May; 45(3):368-378. PubMed ID: 33081424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic control and the risk of tuberculosis in patients with diabetes: A cohort study in a Mediterranean city.
    Antonio-Arques V; Caylà JA; Real J; Moreno-Martinez A; Orcau À; Mauricio D; Mata-Cases M; Julve J; Navas Mendez E; Puig Treserra R; Millet JP; Del Val García JL; Vlacho B; Franch-Nadal J
    Front Public Health; 2022; 10():1017024. PubMed ID: 36466495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations Between Mean HbA1c, HbA1c Variability, and Both Mortality and Macrovascular Complications in Patients with Diabetes Mellitus: A Registry-Based Cohort Study.
    Tan JK; Lim GH; Mohamed Salim NN; Chia SY; Thumboo J; Bee YM
    Clin Epidemiol; 2023; 15():137-149. PubMed ID: 36721457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Normoglycemia in Reducing Microvascular Complications in Patients with Type 2 Diabetes: A Follow-Up Study.
    Ishibashi F; Tavakoli M
    Front Endocrinol (Lausanne); 2018; 9():52. PubMed ID: 29545773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus.
    Santos-Pardo I; Andersson Franko M; Lagerqvist B; Ritsinger V; Eliasson B; Witt N; Norhammar A; Nyström T
    J Am Coll Cardiol; 2024 Jul; 84(3):260-272. PubMed ID: 38752901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.
    Arnold SV; Khunti K; Tang F; Chen H; Cid-Ruzafa J; Cooper A; Fenici P; Gomes MB; Hammar N; Ji L; Saraiva GL; Medina J; Nicolucci A; Ramirez L; Rathmann W; Shestakova MV; Shimomura I; Surmont F; Vora J; Watada H; Kosiborod M
    Am Heart J; 2022 Jan; 243():232-239. PubMed ID: 34666013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of advanced glycation end products is associated with macrovascular events and glycaemic control with microvascular complications in Type 2 diabetes mellitus.
    Yozgatli K; Lefrandt JD; Noordzij MJ; Oomen PHN; Brouwer T; Jager J; Castro Cabezas M; Smit AJ
    Diabet Med; 2018 Apr; ():. PubMed ID: 29687658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited.
    Orchard TJ; Forrest KY; Ellis D; Becker DJ
    Arch Intern Med; 1997 Sep; 157(16):1851-6. PubMed ID: 9290544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.
    Noordzij MJ; Mulder DJ; Oomen PH; Brouwer T; Jager J; Castro Cabezas M; Lefrandt JD; Smit AJ
    Diabet Med; 2012 Dec; 29(12):1556-61. PubMed ID: 22937960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to Failure on Oral Glucose-Lowering Agents for Patients with Type 2 Diabetes: A Retrospective Cohort Study.
    Boye KS; Lage MJ; Kiljański J
    Diabetes Ther; 2021 May; 12(5):1463-1474. PubMed ID: 33837921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes.
    Wu Z; Yu S; Zhang H; Guo Z; Zheng Y; Xu Z; Li Z; Liu X; Li X; Chen S; Zhang J; Tao L; Guo X
    Cardiovasc Diabetol; 2022 Nov; 21(1):262. PubMed ID: 36443820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: A cross-sectional baseline study of 6958 patients in the Danish DD2 cohort.
    Gedebjerg A; Almdal TP; Berencsi K; Rungby J; Nielsen JS; Witte DR; Friborg S; Brandslund I; Vaag A; Beck-Nielsen H; Sørensen HT; Thomsen RW
    J Diabetes Complications; 2018 Jan; 32(1):34-40. PubMed ID: 29107454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2011 Feb; 89 Thesis 1():1-19. PubMed ID: 21443578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic variability in type 2 diabetes mellitus: oxidative stress and macrovascular complications.
    Johnson EL
    Adv Exp Med Biol; 2012; 771():139-54. PubMed ID: 23393677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
    Cerveny JD; Leder RD; Weart CW
    Ann Pharmacother; 1998 Sep; 32(9):896-905. PubMed ID: 9762378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Target HbA1c Between 7 and 7.7% Reduces Microvascular and Macrovascular Events in T2D Regardless of Duration of Diabetes: a Meta-Analysis of Randomized Controlled Trials.
    Sinha B; Ghosal S
    Diabetes Ther; 2021 Jun; 12(6):1661-1676. PubMed ID: 33895981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic Control, Diabetic Complications, and Risk of Dementia in Patients With Diabetes: Results From a Large U.K. Cohort Study.
    Zheng B; Su B; Price G; Tzoulaki I; Ahmadi-Abhari S; Middleton L
    Diabetes Care; 2021 Jul; 44(7):1556-1563. PubMed ID: 34035076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.